Integra LifeSciences Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$411,182	$418,761	$391,918	$434,925
Gross Profit	209,866	219,744	224,237	215,362
EBITDA	38,625	65,873	62,866	66,413
EBIT	38,625	27,738	24,436	27,983
Net Income	14,852	4,482	-4,617	-1,704
Net Change In Cash	411,182	418,761	391,918	434,925
Free Cash Flow	85,731	37,650	-5,045	-19,600
Cash	252,261	214,415	236,809	235,048
Basic Shares	78,577	78,168	76,951	76,753

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$1,635,245	$1,610,527	$1,541,573	$1,557,666
Gross Profit	845,234	882,061	884,735	970,311
EBITDA	-325,415	193,288	255,958	381,787
EBIT	-477,247	52,395	132,446	263,488
Net Income	-516,474	-6,944	67,741	180,550
Net Change In Cash	1,635,245	1,610,527	1,541,573	1,557,666
Cost of Revenue				-46,064
Free Cash Flow	-45,254	24,964	73,090	217,384
Cash	235,048	246,375	276,402	456,661
Basic Shares	76,753	77,010	80,337	83,516